The investment seeks capital appreciation and current income... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EIDIX | 18.10 | 0.12 | +0.67% |
Eaton Vance Global Equity Income I | |||
JVACX | 38.17 | 0.10 | +0.26% |
JPMorgan Value Advantage C | |||
LADPX | 20.34 | 0.05 | +0.25% |
Lord Abbett Developing Growth P | |||
PMIVX | 10.83 | 0.01 | +0.09% |
Putnam Multi-Asset Income R6 | |||
LYFAX | 12.14 | -0.02 | -0.16% |
AlphaCentric Life Sciences & Hlthcare A |
A.I.dvisor indicates that over the last year, FEFAX has been closely correlated with VIVIX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if FEFAX jumps, then VIVIX could also see price increases.
Ticker / NAME | Correlation To FEFAX | 1D Price Change % | ||
---|---|---|---|---|
FEFAX | 100% | +0.73% | ||
VIVIX - FEFAX | 88% Closely correlated | +0.35% | ||
VIVAX - FEFAX | 88% Closely correlated | +0.35% | ||
VVIAX - FEFAX | 88% Closely correlated | +0.35% | ||
DOXGX - FEFAX | 85% Closely correlated | +0.61% | ||
DODGX - FEFAX | 85% Closely correlated | +0.61% | ||
More |